Finemedix Co., Ltd. (KOSDAQ:387570)
South Korea
· Delayed Price · Currency is KRW 7,250.00
+10.00 (0.14%)
At close: Apr 28, 2026
Finemedix Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Operating Revenue | 9,523 | 9,960 | 10,154 | 8,142 | 7,254 | Upgrade
|
| Other Revenue | -0 | -0 | -0 | -0 | - | Upgrade
|
| Revenue | 9,523 | 9,960 | 10,154 | 8,142 | 7,254 | Upgrade
|
| Revenue Growth (YoY) | -4.39% | -1.91% | 24.71% | 12.25% | -8.30% | Upgrade
|
| Cost of Revenue | 4,920 | 4,255 | 4,514 | 3,736 | 3,811 | Upgrade
|
| Gross Profit | 4,603 | 5,705 | 5,640 | 4,406 | 3,443 | Upgrade
|
| Selling, General & Admin | 6,141 | 4,761 | 3,904 | 4,023 | 4,417 | Upgrade
|
| Research & Development | 562.4 | 554.53 | 497.78 | 650.75 | 819.38 | Upgrade
|
| Amortization of Goodwill & Intangibles | 45.61 | 59.4 | 45.97 | 52.11 | 70.68 | Upgrade
|
| Other Operating Expenses | 169.71 | 149.61 | 135.96 | 149.65 | 164.85 | Upgrade
|
| Operating Expenses | 7,184 | 5,841 | 4,767 | 5,067 | 5,756 | Upgrade
|
| Operating Income | -2,580 | -135.69 | 873.58 | -661.25 | -2,313 | Upgrade
|
| Interest Expense | -93.43 | -116.61 | -198.81 | -255.4 | -239.15 | Upgrade
|
| Interest & Investment Income | 117.05 | 39.31 | 48.77 | 34.91 | 7.96 | Upgrade
|
| Earnings From Equity Investments | - | - | - | -200 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -1.08 | 195.54 | -29.72 | 5.9 | 34.46 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.14 | -8.41 | 483.89 | 27.5 | 305.59 | Upgrade
|
| EBT Excluding Unusual Items | -2,557 | -25.86 | 1,178 | -1,048 | -2,204 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -6.15 | Upgrade
|
| Gain (Loss) on Sale of Assets | 4.87 | -180 | - | 1,342 | 10.53 | Upgrade
|
| Pretax Income | -2,552 | -205.86 | 1,178 | 293.67 | -2,200 | Upgrade
|
| Income Tax Expense | -673.85 | -181.71 | 1.84 | 54.09 | -657.02 | Upgrade
|
| Earnings From Continuing Operations | -1,878 | -24.15 | 1,176 | 239.58 | -1,543 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | 133.47 | Upgrade
|
| Net Income | -1,878 | -24.15 | 1,176 | 239.58 | -1,410 | Upgrade
|
| Net Income to Common | -1,878 | -24.15 | 1,176 | 239.58 | -1,410 | Upgrade
|
| Net Income Growth | - | - | 390.80% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 3 | Upgrade
|
| Shares Change (YoY) | 12.35% | 5.42% | 1.75% | 38.53% | 9.53% | Upgrade
|
| EPS (Basic) | -346.00 | -5.00 | 261.11 | 53.20 | -433.59 | Upgrade
|
| EPS (Diluted) | -346.00 | -5.00 | 257.00 | 53.00 | -434.00 | Upgrade
|
| EPS Growth | - | - | 384.91% | - | - | Upgrade
|
| Free Cash Flow | -3,486 | -424.77 | 1,042 | -2,127 | -875.99 | Upgrade
|
| Free Cash Flow Per Share | -642.29 | -87.93 | 227.36 | -472.25 | -269.47 | Upgrade
|
| Gross Margin | 48.34% | 57.28% | 55.55% | 54.12% | 47.46% | Upgrade
|
| Operating Margin | -27.10% | -1.36% | 8.60% | -8.12% | -31.89% | Upgrade
|
| Profit Margin | -19.72% | -0.24% | 11.58% | 2.94% | -19.43% | Upgrade
|
| Free Cash Flow Margin | -36.61% | -4.26% | 10.26% | -26.12% | -12.08% | Upgrade
|
| EBITDA | -1,619 | 859.96 | 1,838 | 298.38 | -1,330 | Upgrade
|
| EBITDA Margin | -17.00% | 8.63% | 18.10% | 3.67% | -18.33% | Upgrade
|
| D&A For EBITDA | 961.79 | 995.65 | 964.01 | 959.62 | 983.4 | Upgrade
|
| EBIT | -2,580 | -135.69 | 873.58 | -661.25 | -2,313 | Upgrade
|
| EBIT Margin | -27.10% | -1.36% | 8.60% | -8.12% | -31.89% | Upgrade
|
| Effective Tax Rate | - | - | 0.16% | 18.42% | - | Upgrade
|
| Advertising Expenses | 207.18 | 114.74 | 189 | 153.45 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.